Minimum Infective Dose of a Lumpy Skin Disease Virus Field Strain from North Macedonia
Infection with <i>Lumpy Skin Disease virus</i> (LSDV), as well as infections with other Capripox virus species, are described as the most severe pox diseases of production animals and are therefore listed as notifiable diseases under the guidelines of the World Organization for Animal He...
Main Authors: | Janika Wolff, Kiril Krstevski, Martin Beer, Bernd Hoffmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/7/768 |
Similar Items
-
High Efficiency of Low Dose Preparations of an Inactivated Lumpy Skin Disease Virus Vaccine Candidate
by: Janika Wolff, et al.
Published: (2022-06-01) -
Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus
by: Janika Wolff, et al.
Published: (2020-12-01) -
Characterization of a Nigerian Lumpy Skin Disease Virus Isolate after Experimental Infection of Cattle
by: Janika Wolff, et al.
Published: (2021-12-01) -
Cross-Protection of an Inactivated and a Live-Attenuated Lumpy Skin Disease Virus Vaccine against Sheeppox Virus Infections in Sheep
by: Janika Wolff, et al.
Published: (2023-03-01) -
Probe-Based Real-Time qPCR Assays for a Reliable Differentiation of Capripox Virus Species
by: Janika Wolff, et al.
Published: (2021-04-01)